Jump to content

Indium (111In) altumomab pentetate

From Wikipedia, the free encyclopedia
(Redirected from Altumomab)
Indium (111In) altumomab pentetate
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetCEA
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

Indium (111In) altumomab pentetate (INN) (USP, indium In 111 altumomab pentetate; trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a chelating agent for the radioisotope indium-111. The drug is used for the diagnosis of colorectal cancer[1][2] but has not been approved for use.[3]

References

[edit]
  1. ^ "lnternational Nonproprietary Names for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (3). 1993. Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-22.
  2. ^ "Cumulartive [sic] Designated Products List". U.S. Food and Drug Administration. Archived from the original on 26 October 2012 – via Scribd Inc.
  3. ^ Kim EE (2001). "Radioimmunodetection of Cancer". Targeted Molecular Imaging in Oncology. New York, NY: Springer. pp. 88-101 (92). ISBN 9780387950280.